Japanese company profile · 3079
DVx Inc.
In its FY2025 public filing, DVx Inc. reports Arrhythmia Business, Ischemia Business. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: ディーブイエックス株式会社
English company name recorded in Japan's EDINET filer data. English company name source
Reported company-wide figures
What does this company do?
What does this company do?
DVx Inc.'s largest reported business by revenue in FY2025 was Arrhythmia Business.
FY2025 · fiscal year ended March 2026 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Arrhythmia Business | ¥45.71B ↗ | 81.6% | — |
| Ischemia Business | ¥4B ↗ | 7.1% | — |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended March 2026. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Arrhythmia Business
- 不整脈事業
- Ischemia Business
- 虚血事業
- Arrhythmia Business
- 不整脈事業
- Ischemia Business
- 虚血事業
- Sales
- 売上高
- Operating profit
- 営業利益
Original Japanese label
- Arrhythmia Business
- 不整脈事業
- Ischemia Business
- 虚血事業
- Arrhythmia Business
- 不整脈事業
- Ischemia Business
- 虚血事業
- Sales
- 売上高
- Operating profit
- 営業利益
Reported Sales by business over time
Reported Sales by business over time
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Arrhythmia Business | — | ¥40.86B | ¥39.31B | ¥42.52B | ¥45.71B |
| Ischemia Business | — | ¥3.06B | ¥2.46B | ¥3.19B | ¥4B |
| Arrhythmia Business | ¥39.37B | — | — | — | — |
| Ischemia Business | ¥3.19B | — | — | — | — |
All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.
What is growing?
What is growing?
No comparable reported revenue growth is available.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2025 · fiscal year ended March 2026
The source document may be in Japanese.
Filing ID: S100YL91
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.